Sequenom, a major provider of fine mapping genotyping, methylation and gene expression analysis solutions, has announced the sales of multiple MassARRAY systems in China. MassARRAY system delivers reliable and specific data from complex biological samples and from genetic target materials available only in trace amounts.
Sequenom’s new MassARRAY customers include the Beijing Genomics Institute (BGI), which plans to initially use the system for its advanced research in viral genetics and later for human genetic projects, and CapitalBio, a life science service company.
Dr Wang Wei, BGI Director of Viral Genotyping, said, MassARRAY is particularly suitable for the high-volume viral genotyping project and other population screening projects that BGI plan to undertake in the near future.